18-FDG imaging in breast cancer
- 1 January 1999
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 29 (1) , 49-56
- https://doi.org/10.1016/s0001-2998(99)80029-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Solid breast nodules: use of sonography to distinguish between benign and malignant lesions.Radiology, 1995
- Positron emission tomography and breast masses: Comparison with clinical, mammographic, and pathological findingsAnnals of Surgical Oncology, 1994
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993
- Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.Radiology, 1993
- The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast DiseaseAnnals of Surgery, 1992
- Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1991
- Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.Journal of Clinical Oncology, 1989
- A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.Journal of Clinical Oncology, 1989
- [18F]Fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1989